Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Keratosis, Actinic 22Brain Neoplasms 10Glioma 7Glioblastoma 7Carcinoma, Basal Cell 4Precancerous Conditions 2Mycosis Fungoides 2Mouth Neoplasms 2Meningioma 2Lymphoma, T-Cell, Cutaneous 2Gliosarcoma 2Basal Cell Nevus Syndrome 2Urinary Bladder Neoplasms 1Squamous Intraepithelial Lesions 1Skull Base Neoplasms 1Skin Neoplasms 1Sezary Syndrome 1Pituitary Neoplasms 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Nonmelanoma Skin Cancers 1Neurofibromatoses 1Neoplasms 1Nasopharyngeal Neoplasms 1Lymphoma 1Leukoplakia 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1

Interventions

Olfactory Training 1Magnetic Resonance Spectroscopy 1Laryngeal Masks 1Indocyanine Green 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Skull Base Neoplasms × Aminolevulinic Acid × Clear all
NCT00870779 2019-06-14

FGR

Dartmouth-Hitchcock Medical Center

Phase 1 Completed
105 enrolled
CNSEndocrine

Brain Neoplasms, Glioma, Meningioma, Pituitary Neoplasms, Skull Base Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡